Select your country or region to view content specific to your country.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Dec 30, 2020
Seegene
donated KRW 3 billion to the Community Chest of Korea to aid COVID-19 victims.
The
donation was delivered at the Community Chest of Korea Center in Jung-gu, Seoul,
on December 30. Seegene's CEO Chun Jong-yoon and CFO Kim
Jeong-yong attended the event, along with Chairman of the Community Chest of
Korea Jong-seok Ye and Secretary-General Yeon-soon Kim.
Seegene
decided to make a donation to help neighbors who are experiencing economic difficulties, including small businesses affected by the re-spread of COVID-19, and
to provide medical equipment to dedicated COVID-19 hospitals to help prevent
the collapse of the medical assistance system. Seegene also donated KRW 1 billion
to the Community Chest of Korea in May to provide medical support to neighbors suffering
from COVID-19.
CEO
Chun Jong-yoon said, “I have been always thinking about the practice of
corporate social responsibility while leading the company for the past 20
years. In particular, this year, all executives and employees did their best,
thinking that the quick supply of COVID-19 diagnostic products is a way to
practice corporate social responsibility. And all of them joined in the
donation to Community Chest of Korea as a social contribution with one mind. I am deeply
grateful for it."
Chairman
of the Community Chest of Korea Jong-seok said, “I would like to thank Seegene for
contributing to the prevention of COVID-19 with an excellent diagnostic kit and donation. We will do our best to support our neighbors
suffering from COVID-19 and to maintain the health care system with the
donations."
Seegene
has contributed to preventing the spread of COVID-19 infection around the world
by rapidly developing and supplying diagnostic kits based on original technology and know-how in the early phase of the COVID-19 pandemic.